The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura-Reference-Cited by-同舟云学术

The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura

Published:2015-03-05 Issue:10 Volume:125 Page:1526-1531
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Lim Wendy¹,Vesely Sara K.²,George James N.²

Affiliation:

1. Department of Medicine, McMaster University, Hamilton, ON, Canada; and

2. Department of Biostatistics and Epidemiology, College of Public Health, Department of Medicine, College of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, OK

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/125/10/1526/1382998/1526.pdf

Reference28 articles.

1. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura.;Rock;N Engl J Med,1991

2. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.;Furlan;N Engl J Med,1998

3. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.;Tsai;N Engl J Med,1998

4. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients.;Bell;N Engl J Med,1991

5. Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximab.;Chemnitz;Am J Hematol,2002

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Features and Relapse/Refractory Disease Risk Factors of Patients with Acquired Thrombotic Thrombocytopenic Purpura in the Western Mediterranean Region of Turkey;OSMANGAZİ JOURNAL OF MEDICINE;2024-07-09

2. How Should Complicated Cases of Thrombotic Thrombocytopenic Purpura With Positive Coombs Test Be Treated?;Cureus;2023-12-18

3. Rituximab in the treatment of immune-mediated thrombotic thrombocytopenic purpura;BLOOD TRANSFUS-ITALY;2023

4. Predictors of relapse and prophylactic management of immune thrombotic thrombocytopenic purpura;Transfusion and Apheresis Science;2023-08

5. Successful Treatment of Refractory Thrombotic Thrombocytopenic Purpura (TTP) With Caplacizumab: A Case Report;Cureus;2023-07-25